IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro

G (Giovanni) Vitale; W.W. de Herder; Peter van Koetsveld; Marlijn Waaijers; W Schoordijk- Verschoor; E Croze; A Colao; S.W.J. Lamberts; Leo Hofland

doi:10.1158/0008-5472.CAN-05-3043

IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro

G (Giovanni) Vitale, W.W. de Herder, Peter van Koetsveld, Marlijn Waaijers, W Schoordijk- Verschoor, E Croze, A Colao, S.W.J. Lamberts, Leo Hofland

Internal Medicine

Research output: Contribution to journal › Article › Academic › peer-review

69 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	554-562
Number of pages	9
Journal	Cancer Research
Volume	66
Issue number	1
DOIs	https://doi.org/10.1158/0008-5472.CAN-05-3043
Publication status	Published - 2006

Access to Document

10.1158/0008-5472.CAN-05-3043

http://hdl.handle.net/1765/56252

Cite this

@article{2874daed639147e78416731ad096220a,

title = "IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro",

author = "Vitale, {G (Giovanni)} and {de Herder}, W.W. and {van Koetsveld}, Peter and Marlijn Waaijers and {Schoordijk- Verschoor}, W and E Croze and A Colao and S.W.J. Lamberts and Leo Hofland",

year = "2006",

doi = "10.1158/0008-5472.CAN-05-3043",

language = "Undefined/Unknown",

volume = "66",

pages = "554--562",

journal = "Cancer Research",

issn = "0008-5472",

publisher = "American Association for Cancer Research Inc.",

number = "1",

}

TY - JOUR

T1 - IFN-beta is a highly potent inhibitor of gastroenteropancreatic neuroendocrine tumor cell growth in vitro

AU - Vitale, G (Giovanni)

AU - de Herder, W.W.

AU - van Koetsveld, Peter

AU - Waaijers, Marlijn

AU - Schoordijk- Verschoor, W

AU - Croze, E

AU - Colao, A

AU - Lamberts, S.W.J.

AU - Hofland, Leo

PY - 2006

Y1 - 2006

U2 - 10.1158/0008-5472.CAN-05-3043

DO - 10.1158/0008-5472.CAN-05-3043

M3 - Article

VL - 66

SP - 554

EP - 562

JO - Cancer Research

JF - Cancer Research

SN - 0008-5472

IS - 1

ER -